Drug Discovery: venture funds and startups
Fusion42 tracks 45 venture funds in Drug Discovery with $15.2B in combined assets under management, and 3 startups that have raised $26M between them. The data below is live from the same database that powers Raise and Scout, and is continuously enriched as new rounds and funds are announced.
Part of the Raise fund database and the Scout startup database by Fusion42 — the same live data Arthur, Fusion42's AI co-founder, reasons over.
active funds in Drug Discovery include AlleyCorp Fund II, Criteria Bio Ventures, Yosemite Fund II, Bertelsmann Healthcare Investments and Genesys University Seed Fund; startups in Drug Discovery include Waypoint Bio, SwishX and Thalia Therapeutics. Each name links through to a full machine-readable profile — its backers, rounds and related Wire analysis — and the tables below list every entity Fusion42 tracks in Drug Discovery, refreshed as new rounds and funds are announced.
Funds in Drug Discovery (45 tracked)
Startups in Drug Discovery (3 tracked)
| Startup | Stage | HQ | Raised |
|---|---|---|---|
| Waypoint Bio | series-a | United States | $20M |
| SwishX | seed | India | $2M |
| Thalia Therapeutics | — | United Kingdom | $3M |